A more recent study found methylation differences at only one of the CpG sites in the BRCA1 promoter in the blood of breast cancer women and pre-diagnostic breast cancer cases and again here detected methylation level difference were less than 2%11. This evidence concerns the gene BRCA1 and breast cancer.